Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial.

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clin Transl Radiat Oncol. 2018 Nov; 13:19-23.

View in: PubMed

authors with profiles

ADAM S GARDEN
PETER A BALTER
GARY BRANDON GUNN
STEVEN JAY FRANK
DAVID ROSENTHAL
YING YUAN
JACK PHAN
STEPHEN YENZEN LAI
MICHALIS ARISTOPHANOUS
CLIFTON FULLER